Navigation Links
Statement of HDMA President and CEO John M. Gray on the Importation of Prescription Drugs
Date:12/9/2009

ARLINGTON, Va., Dec. 9 /PRNewswire-USNewswire/ -- John M. Gray, President and Chief Executive Officer of the Healthcare Distribution Management Association (HDMA), issued the following statement in reaction to Senate Amendment 2793 to the Patient Protection and Affordable Care Act, which would allow for importation of prescription medications:

"Importation of prescription drugs from foreign countries, as Senator Dorgan and others propose to allow, would compromise the secure U.S. distribution system by increasing the likelihood of entry for counterfeit or adulterated medicines. Efforts to sell counterfeit or adulterated medications produced overseas have become far more sophisticated in just the past few years. Rather than exposing U.S. patients to such risks, Congress should enhance the safety and security of the domestic supply chain through enactment of a uniform federal pedigree standard.

"We are very concerned about provisions in the legislation which call for implementation of a track-and-trace system by 2012. While this effort to address patient safety is well-intentioned, it is not aligned with industry capabilities, technological developments, or federal guidance on product serialization. States that have looked at track-and-trace issues in depth understand the complexity of such an undertaking. That is why the most aggressive time horizons established by states for track-and-trace implementation begin in 2015.

"HDMA and its members support the enhancement of pharmaceutical supply chain security through establishment of a uniform federal pedigree standard. This would facilitate the flow of prescription medicines between states and enable manufacturers, distributors, pharmacies, regulators and law enforcement to identify and prevent the entry of illicit products into our drug supply.

"Before opening our borders, a realistic, comprehensive approach is needed to counter these threats, facilitate interstate commerce and reconcile inconsistencies among the patchwork of state requirements currently in place. Importation is and will be an unsound policy until these issues are addressed."

To learn more about HDMA's position on importation, health reform and other issues, visit www.healthcaredistribution.org.

About HDMA
HDMA is the national association representing primary healthcare distributors, the vital link in the healthcare system. Each business day, HDMA member companies ensure that more than nine million prescription medicines and healthcare products are safely delivered to more than 165,000 pharmacies, hospitals, nursing homes, physician offices, clinics and others nationwide. HDMA and its members work daily to provide value and contain costs, saving the nation's healthcare system an estimated $32 billion per year. For more information, visit www.HealthcareDistribution.org.

SOURCE Healthcare Distribution Management Association


'/>"/>
SOURCE Healthcare Distribution Management Association
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Statement from AAHSA CEO Larry Minnix on the Failure of the Thune Amendment
2. Natural Products Association Issues Statement on DEAs Steroid Classification Action
3. AAHSA Statement on Passage of Bennet Health Reform Amendment
4. Natural Products Association Issues Statement on New Supplement Safety Campaign
5. Statement of Support: Strengthening Oral Health Care is Key Part of Health Reform
6. Democratic National Committee Chairman Tim Kaines Statement on the Senates Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation
7. Statement by the Scientific Advisory Board of the Patient Advocate Foundation/National Patient Advocate Foundation on Changes to the USPSTF Mammography Guidelines
8. Pelosi Statement on House Passage of Medicare Physician Payment Reform Act
9. Democratic National Committee Chairman Issues Statement Praising the Patient Protection and Affordable Care Act
10. Statement of Robert Greenstein, Executive Director, Center on Budget and Policy Priorities, on the New Senate Health Reform Bill
11. Pelosi Statement on Senate Health Insurance Reform Bill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... ... weeks Nature’s Tears® EyeMist®, the signature product of her research center at Bio-Logic ... the world’s largest population and the greatest number of sufferers of blindness. “We ...
(Date:7/21/2017)... TORONTO, ONTARIO, CANADA (PRWEB) , ... July 21, ... ... may give insight into why concussion rates are on the rise, say researchers ... Annual Meeting today in Toronto, Ontario, Canada. , “The combination of evaluating the ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... and application performance monitoring (APM) solutions, has expanded its footprint inside the ... According to Peter Ohrenberger, sales director at Nastel, “We’ve replaced an existing ...
(Date:7/20/2017)... ATLANTA, Ga. (PRWEB) , ... July 20, 2017 , ... ... and equal access to medicine for everyone affected by diabetes, is teaming up with ... the five-day global event kicks off on July 24th. , “Team Type 1’s ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... Webinar**, Aug. 9, 2017 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/mdqualitydata ... and boosting quality. , It’s known as the “CY2016 Annual FDA Medical Device ...
Breaking Medicine News(10 mins):
(Date:7/20/2017)... 20, 2017  Prime Therapeutics LLC (Prime) released this statement ... following today,s Institute for Clinical and Economic Review,s (ICER) ... effectiveness and value of abuse-deterrent formulations (ADF) of opioids. Prime ... at the meeting. ... benefit to the use of abuse-deterrent formulations (ADF) in opioids ...
(Date:7/15/2017)... 15, 2017 Enterin Inc., a Philadelphia ... disease (PD), today announced the completion of a $12.7 million ... Ventures III, as well as the participation of existing investors. ... to have the support of New Ventures III and our ... validation of the potential of our platform technology to transform ...
(Date:7/13/2017)... 2017  Centurion Medical Products, a leader in medical product innovation ... impaction removal device for hospice patient care. ... Centurion Medical Products ... Patient pain management and emotional comfort are part of ... patient pain while preventing unneeded emergency department admission due to severe ...
Breaking Medicine Technology: